Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) traded down 9.16% on last day of the week, and closed at $7.63. The stock traded in the band of $7.50 and $7.81 and the range for the 52-week is $2.52 and $13.50.

SAN DIEGO, April 26, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that it will provide a corporate update and discuss first quarter 2013 financial results after the NASDAQ Global Select Market closes on Thursday, ...

Yesterday, when it announced its results, Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) had said that it was withdrawing its application for approval of its weight loss drug Belviq in Europe.

Analysts are downgrading their ratings on Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) after the company said that it is taking back its application for approval of Belviq, a weight loss drug, in Europe.

Arena Pharmaceuticals Inc (NASDAQ:ARNA):Tuesday's trading session saw Arena Pharmaceuticals, Inc (NASDAQ:ARNA) shares rising by 0.88 %. The closing price of $8.03, moved on to touch an intraday high of $8.05 before sliding down to $7.95 per ...

Related Topics. Stocks � · Markets � · Healthcare �. NEW YORK | Thu May 2, 2013 4:07pm EDT. NEW YORK May 2 (Reuters) - Arena Pharmaceuticals Inc : * Shares fell 14 percent after the bell following the release of its results. Stocks · Markets ...

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) shares increased 5.85% to $8.34. The company, on April 5, announced the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 ...

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) shares increased 5.72% to $7.95. The company, on May 2, provided a corporate update and reported financial results for the first quarter ended March 31, 2013.

Arena Pharmaceuticals Inc.'s (NASDAQ:ARNA) loss (omitting special items) of 10 cents per share in the first quarter of 2013 was lesser than the year-earlier loss of 15 cents per share.

Let's also review hedge fund and insider activity in other stocks similar to Infinity Pharmaceuticals Inc. (NASDAQ:INFI). These stocks are Incyte Corporation (NASDAQ:INCY), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Questcor Pharmaceuticals Inc ...